Novel Resorcinol Dibenzyl Ether-Based PD-L1 Inhibitors Modulate Lipid Metabolism for Enhanced Tumor Immunotherapy
用户6X7Ch8WUQ_gI
1个月前
55
10
已完结
1. 系统已在2026-03-27 11:40:31对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c02527
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02527
其他信息:
出版社: American Chemical Society (ACS)
作者: Zichao Yang; Ziqing Liu; Jiayi Zhou; Pengfei Song; Abdullah Mohsan Nasser Saleh; Jianwei Xu; Xixiang Yang; Yangcheng Ai; Yichang Ren; Zhijie Wang; Jianjun Chen
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c02527
